Considerations for High-Efficiency Genome Editing of Human Pluripotent Stem Cells
Genome editing of hPSCs allows for the generation of isogenic hPSC lines for disease models, by controlling for variation in genetic background between individuals. In this seminar, Ashley reviews STEMCELL’s recommended tools for efficient Cas9 genome editing, and reviews the challenges associated with working with ES/iPS cells as well as tips for overcoming them and maintaining cell quality throughout a project.
Publish Date:
May 29, 2020
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Optimized Workflows for High-Efficiency Genome Editing in Stem and Primary Cell Types
Publish Date: September 09, 2019 -
Nature Research Round Table: Genome Editing in Human Pluripotent Stem Cells
Publish Date: November 01, 2019 -
Improving Genome Editing with Enhanced CRISPR-Cas Nucleases
Publish Date: May 21, 2019
Explore Our Products
-
Defined supplement for improving survival of human ES and iPS cells in single-cell workflows -
Healthy Control Human iPSC Line, Female, SCTi003-A
Human pluripotent stem cell line, frozen -
Defined supplement for single-cell cloning of human ES and iPS cells -
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells
